Skip to Main Content
New research shows Virta is an effective off-ramp from GLP-1s for sustained weight loss
Member Log In
Learn how Virta's research-backed approach helps people lose weight, and reverse type 2 diabetes and prediabetes
How Virta Works
Personalized, always-on care for weight-loss and diabetes reversal
Our members are taking back their lives. Hear their stories.
A new standard for results in metabolic care
An evidence-backed approach
Virta partners with forward-thinking organizations to help them save money and transform the lives of their members
Save money and transform your organization's health
Control Rx costs and complete your portfolio by offering reversal
Help your patients take back their lives
Your go-to place for additional background the benifits of reversing disease, and the leaders who are bringing it to their organizations
Resources For Organizations
Case studies, events, webinars, and more
GLP-1s and Weight Loss
Virta as an offramp and alternative to GLP-1 use
Learn how Virta ls closing gaps in metabolic care
Reversing Type 2 Diabetes
What you need to know about diabetes reversal
About Type 2 Diabetes
Virta answers key questions about type 2 diabetes
2024 Update: How Health Plan Leaders Are Handling the GLP-1 Cost Crisis [Survey Report]
Making the Switch: Why Reversal is Replacing Management for Diabetes and Weight Loss
Assessing Solutions to Improve Metabolic Health
Virta is setting a new standard for diabetes, prediabetes, and weight loss care
We're on a mission to solve our nation's diabetes and obesity epidemics
Help us transform people's health
The latest Virta announcements and news coverage
Founding and executive team leadership
Research, member stories, and more
Already a member? Log In
Science & Research
Science & Research
How Do GLP-1 Drugs Like Ozempic Work?
What Is The Link Between COVID and Diabetes?
New Research at ADA’s 83rd Scientific Sessions: Virta Helps Members Improve Kidney Function, Sleep, and More
New Data Shows Virta Closes Gaps in Diabetes Care for Underserved Populations
Virta’s Approach Improves Kidney Function, Offering Hope to Patients With Chronic Kidney Disease
Using Virta’s Reversal Program To Help The 88 Million Americans With Prediabetes
The Emerging Science Connecting Glycemic Control to Improved COVID-19 Outcomes
COVID-19 and Diabetes: What we know and don't know
The Science Behind COVID-19 and Type 2 Diabetes
Two Year Clinical Trial Outcomes Provide Evidence for Long-Term Benefits of Virta for Type 2 Diabetes
Reducing the Cost of Insulin by Utilizing Virta's Metabolic Nutrition Therapy
Steve Tashjian on Carbohydrate Restriction in Soccer
1 / 5
By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our
for more information.
These items are required to enable basic website functionality.
These items are used to deliver advertising that is more relevant to you and your interests. They may also be used to limit the number of times you see an advertisement and measure the effectiveness of advertising campaigns. Advertising networks usually place them with the website operator’s permission.
These items allow the website to remember choices you make (such as your user name, language, or the region you are in) and provide enhanced, more personal features. For example, a website may provide you with local weather reports or traffic news by storing data about your current location.
These items help the website operator understand how its website performs, how visitors interact with the site, and whether there may be technical issues. This storage type usually doesn’t collect information that identifies a visitor.
Confirm My Choices
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.